VaxGen Comes Out of a Torrid Year and Merges With Raven

Struggling U.S. vaccine maker VaxGen, which recently announced major job cuts and was thought to be putting itself up for sale, has announced plans to merge with Raven Biotechnologies.
Pharma Times